May 10, 2022
Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma
Media
May 06, 2022
Nordic Nanovector ASA: Invitation to First Quarter 2022 Results Presentation and Webcast
May 05, 2022
Interim report January – March 2022
May 04, 2022
Xeris Biopharma to Report First Quarter 2022 Financial Results on May 11, 2022
May 04, 2022
BONESUPPORT Holding AB (publ) – Publishes Q1 2022 interim report
May 04, 2022
Oncopeptides publishes Q1 report 2022
May 03, 2022
Pulmonx Reports First Quarter 2022 Financial Results
May 03, 2022
Adcendo Appoints Dominik Mumberg, PhD, as Chief Scientific Officer
May 03, 2022
Nordic Nanovector: New Publication Highlights Synergistic Potential of CD37-targeted Radioimmunoconjugate Humalutin® in Combination with the PARP-inhibitor Olaparib
May 03, 2022
Targovax ASA: Invitation to presentation of Targovax’s first quarter 2022 results, Thursday 12 May